Analysts’ Viewpoint
Intrathecal pain pump implants have the ability to reduce debilitating pain and administer a drug in low doses. These implants offer lesser side-effects and more rapid therapeutic action as compared to other forms of medication. Increase in number of people in the U.S. suffering from chronic pain is driving intrathecal pumps demand. Prevalence of chronic pain is also rising in other parts of the world. Surge in demand for intrathecal pump implants for the treatment of chronic pain is likely to propel market progress in the next few years.
Researchers have developed advanced intrathecal drug pump that can deliver multiple intrathecal pump medications via a single infusion pump. However, usage of combination therapy in a single reservoir could result in drug stability issues and a complex dosing challenge with respect to varying concentration and administration rates for each drug. Furthermore, recent recall of intrathecal pumps owing to battery failure and broken components is hampering business growth. More product modifications are required to assure precise and accurate drug administration with minimal error.
Intrathecal pumps are implantable infusion devices surgically placed under the patient’s skin in the abdomen. These can deliver medication through a small flexible tube, called a catheter, to the spine. These intrathecal drug pain pump implants are capable of delivering precise doses of medication from one or any combination of reservoirs without complex pumping, and are generally opted when a patient seeks long-term medication and other alternatives are expensive or less effective.
A drug can be infused over an extended period and can be delivered at constant or variable rates by regulating the intrathecal pumps drug delivery as per physician specifications. The drug reservoir is refilled with the help of an external needle injection via a self-sealing septum in the implantable infusion pump. These pumps are intended for use in spasticity management and chronic pain for delivering potent medicines in the intrathecal space, which allows the administration of drugs in very low doses. This reduces the side effects associated with the drugs.
Intrathecal drug delivery is based on the principle that effective analgesia can be achieved with the help of certain drugs, wherein adequate concentrations cannot be achieved by systemic administration or require high systemic doses. The smaller doses needed for intrathecal drug administration also reduce the side-effects as compared to systemic administration.
The COVID-19 pandemic had a negative effect on the industry. Several countries had to postpone non-essential surgeries and patient visits during the breakout year of COVID-19. Healthcare assets such as ventilators, personal protective equipment, and medical staff were rerouted for the management of the pandemic, which prompted the suspension of spinal surgery during the pandemic. This led to a substantial decline in overall non-emergency procedures and treatments.
The pandemic affected various procedures such as intrathecal device placement and procedure feasibility testing. Companies in the intrathecal pumps business reported a decline in revenue and demand due to the pandemic. However, demand is showing signs of recovery, as restrictions on movement ease across the globe.
Increase in number of people suffering from chronic pain and cancer is a major factor fueling the global market. Intrathecal pumps are widely used to administer drugs using the intrathecal route during the treatment of these diseases. According to International Agency for Research on Cancer (IARC) estimates, around 17.0 million new cancer cases and 9.5 million cancer deaths were reported globally in 2018. The global burden is expected to increase to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to surge in the geriatric population.
Changing lifestyles, rapid urbanization, and demographic changes are major factors contributing to the increase in people with disease-causing pain. Thus, rise in prevalence of chronic pain and pain related to cancer is expected to drive the demand for intrathecal pumps for managing cancer pain.
Technological developments are bolstering the global intrathecal pumps business. The trend is expected to continue during the forecast period. Manufacturers are focusing on the development of innovative products in order to gain a competitive edge over the competitors. Advent of a smart intrathecal pumps management system helps clinicians with programming and calculating dose delivery rates, thereby helping in providing better patient care. These innovations have driven the demand for intrathecal infusion pumps. Technological developments leading to enhanced product performance are expected to drive the market from 2022 to 2031.
In terms of product type, the programmable segment accounted for major intrathecal pumps market share in 2021. In February 2020, Flowonix Medical, Inc. announced the U.S. Food and Drug Administration (FDA) approval to commercialize the Prometra ii programmable pump system for use with intrathecal baclofen. Flowonix introduced the Prometra II 40mL pump in the U.S. in November 2019.
Likewise, in April 2017, Medtronic announced the U.S. Food and Drug Administration (FDA) approval to market the SynchroMed II GW3/FT/DLC pump system, a programmable intrathecal pump. Thus, increase in launch of new products is likely to augment the programmable segment during the forecast period.
Based on application, the chronic pain segment dominated the global intrathecal pumps industry in 2021. The segment is projected to grow at a moderate pace during the forecast period. Intrathecal pumps have shown significant improvement in patients with chronic pain by enabling the controlled administration of drugs.
Furthermore, the prevalence of chronic pain is high across the world. In a study published by a national health publication, around 20% of the U.S. adults experienced chronic pain in 2020, with an estimated US$ 560 Bn spent annually on direct medical costs. Therefore, increase in new cases of chronic pain is propelling the chronic pain segment.
In terms of end-user, the hospitals segment accounted for major share of the global market in 2021. Around 80% to 90% of intrathecal procedures are performed at hospitals owing to availability of adequate infrastructure and specialists. However, the ambulatory surgical centers segment is projected to grow at a rapid pace during the forecast period due to rise in reimbursement and increase in approvals for intrathecal procedures in these settings.
North America accounted for largest share of the global market for intrathecal pumps in 2021. The region is anticipated to dominate the industry during the forecast period. Surge in demand for intrathecal procedures, high prevalence of cancer & chronic pain, and technological advancements are driving market expansion in the region. The U.S. is a growth engine of the market in North America due to the implementation of favorable reimbursement policies for intrathecal procedures.
Europe was the second largest market in 2021. Favorable regulatory & reimbursement scenarios and approval of intrathecal devices are expected to propel intrathecal pumps market growth in the region. The market in Asia Pacific is projected to grow at a rapid pace during the forecast period. This is ascribed to growing economy and strengthening insurance policies. Economic growth in developing countries in the region is expected to increase the disposable income of the patient population, which in turn is likely to propel healthcare expenditure.
Economic growth has also increased healthcare infrastructure investment in several countries in Asia, which is likely to drive the adoption of hospital equipment. Governments in these nations in collaboration with private insurance companies are focusing on the improvement of healthcare coverage in order to support access to better healthcare facilities.
This report includes vital information about the key players operating in the global intrathecal pumps market. Companies focus on diverse strategies such as product launches, divestiture, merger & acquisition (M&A), and partnerships to strengthen their position in the market. Medtronic, Inc., Flowonix, Inc. and Tricumed Medizintechnik GmbH are the prominent players operating in this market.
Players in the report have been profiled based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 272.1 Mn |
|
Forecast (Value) in 2031 |
More than US$ 405.6 Mn |
|
Compound Annual Growth Rate (CAGR) |
4.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The industry was valued at US$ 272.1 Mn in 2021
It is projected to reach more than US$ 405.6 Mn by 2031
The industry is anticipated to grow at a CAGR of 4.5% from 2022 to 2031
Increase in adoption of programmable pumps and rise in in prevalence of chronic pain
The programmable pumps segment held largest share of 81.4% in 2021
North America is expected to account for major share of the business during the forecast period
Medtronic, Inc., Flowonix, Inc., and Tricumed Medizintechnik GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intrathecal Pumps Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intrathecal Pumps Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Disease incidence and prevalence
5.2. Technological Advancements
5.3. Regulatory Scenario across the globe/key countries
5.4. COVID-19 Impact Analysis
6. Global Intrathecal Pumps Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Programmable
6.3.2. Constant Rate
6.4. Market Attractiveness Analysis, by Product Type
7. Global Intrathecal Pumps Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Chronic Pain
7.3.2. Spasticity Management
7.4. Market Attractiveness Analysis, by Application
8. Global Intrathecal Pumps Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Intrathecal Pumps Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Intrathecal Pumps Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Programmable
10.2.2. Constant Rate
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Chronic Pain
10.3.2. Spasticity Management
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Intrathecal Pumps Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Programmable
11.2.2. Constant Rate
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Chronic Pain
11.3.2. Spasticity Management
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Intrathecal Pumps Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Programmable
12.2.2. Constant Rate
12.2.3. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Chronic Pain
12.3.2. Spasticity Management
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Intrathecal Pumps Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Programmable
13.2.2. Constant Rate
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Chronic Pain
13.3.2. Spasticity Management
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Intrathecal Pumps Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Programmable
14.2.2. Constant Rate
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Chronic Pain
14.3.2. Spasticity Management
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Medtronic, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Flowonix, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Tricumed Medizintechnik GmbH
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
List of Tables
Table 01: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031
Table 03: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031
Table 04: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031
Table 09: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031
Table 10: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 11: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 13: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 14: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031
Table 15: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031
Table 16: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 17: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 19: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 20: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031
Table 21: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031
Table 22: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 25: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 26: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031
Table 27: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031
Table 28: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 29: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 31: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 32: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031
Table 33: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031
Table 34: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 35: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 36: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Intrathecal Pumps Market
Figure 02: Global Intrathecal Pumps Market Size (US$ Mn) Forecast, 2017–2031
Figure 03: Global Intrathecal Pumps Market Value Share, by Product Type (2021)
Figure 04: Global Intrathecal Pumps Market Value Share, by Application (2021)
Figure 05: Global Intrathecal Pumps Market Value Share, by End-user (2021)
Figure 06: Global Intrathecal Pumps Market Value Share, by Region (2021)
Figure 07: Global Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031
Figure 08: Global Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 09: Global Intrathecal Pumps Market Value Share, by Application, 2021 and 2031
Figure 10: Global Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031
Figure 11: Global Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031
Figure 12: Global Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031
Figure 13: Global Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 14: Global Intrathecal Pumps Market Value Share, by Region, 2021–2031
Figure 15: Global Intrathecal Pumps Market Attractiveness Analysis, by Region, 2021–2031
Figure 16: North America Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031
Figure 17: North America Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 18: North America Intrathecal Pumps Market Value Share, by Application, 2021 and 2031
Figure 19: North America Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031
Figure 20: North America Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031
Figure 21: North America Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031
Figure 22: North America Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 23: North America Intrathecal Pumps Market Value Share, by Country, 2021–2031
Figure 24: North America Intrathecal Pumps Market Attractiveness Analysis, by Country, 2021–2031
Figure 25: Europe Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031
Figure 26: Europe Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 27: Europe Intrathecal Pumps Market Value Share, by Application, 2021 and 2031
Figure 28: Europe Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031
Figure 29: Europe Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031
Figure 30: Europe Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031
Figure 31: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 32: Europe Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031
Figure 33: Europe Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 34: Asia Pacific Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031
Figure 35: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 36: Asia Pacific Intrathecal Pumps Market Value Share, by Application, 2021 and 2031
Figure 37: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031
Figure 38: Asia Pacific Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031
Figure 39: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031
Figure 40: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 41: Asia Pacific Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031
Figure 42: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 43: Latin America Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031
Figure 44: Latin America Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 45: Latin America Intrathecal Pumps Market Value Share, by Application, 2021 and 2031
Figure 46: Latin America Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031
Figure 47: Latin America Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031
Figure 48: Latin America Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031
Figure 49: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 50: Latin America Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031
Figure 51: Latin America Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 52: Middle East & Africa Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031
Figure 53: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 54: Middle East & Africa Intrathecal Pumps Market Value Share, by Application, 2021 and 2031
Figure 55: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031
Figure 56: Middle East & Africa Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031
Figure 57: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031
Figure 58: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 59: Middle East & Africa Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031
Figure 60: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 61: Global Intrathecal Pumps Market Share Analysis, by Company, 2021 (Estimated)
Figure 62: Global Intrathecal Pumps Market Performance, by Company, 2021
Figure 63: Competition Matrix Novartis AG and Allergan plc (AbbVie Inc.)
Figure 64: Competition Matrix Bausch Health Companies Inc. and Alma Lasers (Fosun Pharmaceutical Co., Ltd.)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Intrathecal Pumps Market
